Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 243-252

  Kaneko, Akira ^a,b,c   Chaves, Luis F ^c,d   Taleo, George ^e   Kalkoa, Morris ^e   Isozumi, Rie ^b   Wickremasinghe, Renu ^f   Perlmann, Hedvig ^g   Takeo, Satoru ^h   Tsuboi, Takafumi ⁱ   Tachibana, Shin Ichiro ^j   Kimura, Masatsugu ^b   Björkman, Anders ^a   Troye Blomberg, Marita ^g   Tanabe, Kazuyuki ^j   Drakeley, Chris ^k  

^a KAROLINSKA INSTITUTE   (Sweden)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d UNIVERSIDAD NACIONAL   (Costa Rica)

^e Ministry of Health   (Vanuatu)

^f UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^g STOCKHOLM UNIVERSITY   (Sweden)

^h KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ EHIME UNIVERSITY   (Japan)

^j OSAKA UNIVERSITY   (Japan)

^k LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; INSECTICIDE; PARASITE ANTIGEN; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY RESPONSE; ARTICLE; BED NET; CHILD; ENDEMIC DISEASE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALE; MICROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE INFECTION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROEPIDEMIOLOGY; VANUATU;

EID: 84890827547     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00931-13     Document Type: Article

References (51)

1. Bhattarai A, Ali AS, Kachur SP, Mårtensson A, Abbas AK, Khatib R, Al-Mafazy AW, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, Kaneko A, Björkman A. 2007. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 4:e309. http://dx.doi.org/10.1371/journal.pmed.0040309.
2. Fegan GW, Noor AM, Akhwale WS, Cousens S, Snow RW. 2007. Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet 370:1035-1039. http://dx.doi.org/10.1016/S0140-6736(07)61477-9.
3. Feachem RG, The Malaria Elimination Group. 2009. Shrinking the malaria map: a guide on malaria elimination for policy makers. University of California, San Francisco, CA.
4. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. 2007. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 77(6 Suppl.):79-87. http://www.ajtmh.org/content/77/6_Suppl/79.long.
5. Bruce-Chwatt LJ, Draper CC, Konfortion P. 1973. Seroepidemiological evidence of eradication of malaria from Mauritius. Lancet ii:547-551.
6. Kaneko A, Taleo G, Kalkoa M, Yaviong J, Reeve PA, Ganczakowski M, Shirakawa C, Palmer K, Kobayakawa T, Björkman A. 1998. Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago. Acta Trop. 70:285-302. http://dx.doi.org/10.1016/S0001-706X(98)00035-7.
7. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Björkman A. 2000. Malaria eradication on islands. Lancet 356:1560-1564. http://dx.doi.org/10.1016/S0140-6736(00)03127-5.
8. Troye-Blomberg M, Perlmann H, Patarroyo ME, Perlmann P. 1983. Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin. Exp. Immunol. 53:345-353.
9. Ihalamulla RL, Mendis KN. 1987. Plasmodium vivax: isolation of mature asexual stages and gametocytes from infected human blood by colloidal silica (Percoll) gradient centrifugation. Trans. R. Soc. Trop. Med. Hyg. 81:25-28. http://dx.doi.org/10.1016/0035-9203(87)90271-9.
10. Tsuboi T, Takeo S, Iriko H, Jin L, Tsuchimochi M, Matsuda S, Han ET, Otsuki H, Kaneko O, Sattabongkot J, Udomsangpetch R, Sawasaki T, Torii M, Endo Y. 2008. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect. Immun. 76:1702-1708. http://dx.doi.org/10.1128/IAI.01539-07.
11. Evengård B, Linder E, Lundbergh P. 1988. Standardization of a filterpaper technique for blood sampling. Ann. Trop. Med. Parasitol. 82:295-303.
12. Perlmann H, Perlmann P, Berzins K, Wåhlin B, Troye-Blomberg M, Hagstedt M, Andersson I, Högh B, Petersen E, Björkman A. 1989. Dissection of the human-antibody response to the malaria antigen Pf155/Resa into epitope specific components. Immunol. Rev. 112:115-132. http://dx.doi.org/10.1111/j.1600-065X.1989.tb00555.x.
13. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C. 2009. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One 4:e6083. http://dx.doi.org/10.1371/journal.pone.0006083.
14. McCullagh P, Nelder JA. 1989. Generalized linear models, 2nd ed. CRC Press, Boca Raton, FL.
15. Tanabe K, Escalante A, Sakihama N, Honda M, Arisue N, Horii T, Culleton R, Hayakawa T, Hashimoto T, Longacre S, Pathirana S, Handunnetti S, Kishino H. 2007. Recent independent evolution of msp1 polymorphism in Plasmodium vivax and related simian malaria parasites. Mol. Biochem. Parasitol. 156:74-79. http://dx.doi.org/10.1016/j.molbiopara.2007.07.002.
16. Sakihama N, Ohmae H, Bakote B, Kawabata M, Hirayama K, Tanabe K. 2006. Limited allelic diversity of Plasmodium falciparum msp1 from populations in the Solomon Islands. Am. J. Trop. Med. Hyg. 74:31-40. http://www.ajtmh.org/content/74/1/31.long.
17. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol. Biochem. Parasitol. 58:283-292. http://dx.doi.org/10.1016/0166-6851(93)90050-8.
18. Chaves LF, Kaneko A, Pascual M. 2009. Random, top-down or bottom-up co-existence of parasites: malaria population dynamics in multiparasitic settings. Ecology 90:2414-2425. http://dx.doi.org/10.1890/08-1022.1.
19. Boyd MF, Matthews CB. 1939. Further observations on the duration of immunity to the homologous strain of Plasmodium vivax. Am. J. Trop. Med. 19:63-67.
20. Boyd MF. 1947. A review of immunity to vivax malaria. J. Natl. Malar. Soc. 6:12-31.
21. Lepers JP, Deloron P, Fontenille D, Coulanges P. 1988. Reappearance of falciparum malaria in central highland plateaux of Madagascar. Lancet i:586.
22. Deloron P, Chougnet C. 1992. Is immunity to malaria really short-lived? Parasitol. Today 8:375-378. http://dx.doi.org/10.1016/0169-4758(92)90174-Z.
23. Rolfes MA, McCarra M, Magak NG, Ernst KC, Dent AE, Lindblade KA, John CC. 2012. Development of clinical immunity to malaria in highland areas of low and unstable transmission. Am. J. Trop. Med. Hyg. 87:806-812. http://dx.doi.org/10.4269/ajtmh.2012.11-0530.
24. Coatney GR, Cooper WC, Young MD. 1950. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J. Natl. Malar. Soc. 9:381-396.
25. Baird JK. 1995. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today 11:105-111. http://dx.doi.org/10.1016/0169-4758(95)80167-7.
26. Cook J, Kleinschmidt I, Schwabe C, Nseng G, Bousema T, Corran PH, Riley EM, Drakeley CJ. 2011. Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One 6:e25137. http://dx.doi.org/10.1371/journal.pone.0025137.
27. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K. 2008. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect. Immun. 76:2240-2248. http://dx.doi.org/10.1128/IAI.01585-07.
28. Noland GS, Hendel-Paterson B, Min XM, Moormann AM, Vulule JM, Narum DL, Lanar DE, Kazura JW, John CC. 2008. Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect. Immun. 76:5721-5728. http://dx.doi.org/10.1128/IAI.00591-08.
29. Cohen S, McGregor IA, Carrington S. 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192:733-737. http://dx.doi.org/10.1038/192733a0.
30. Druilhe P, Perignon JL. 1994. Mechanisms of defense against Plasmodium falciparum asexual blood stages in humans. Immunol. Lett. 41:115-120. http://dx.doi.org/10.1016/0165-2478(94)90118-X.
31. Loureiro LF, Cesario AM, Franco AS, Rosário VE. 1996. Malaria in São Tomé and Principe: prevalence and drug-susceptibility. Ann. Trop. Med. Parasitol. 90:223-224.
32. Arez AP, Snounou G, Pinto J, Sousa CA, Modiano D, Ribeiro H, Franco AS, Alves J, do Rosario VE. 1999. A clonal Plasmodium falciparum population in an isolated outbreak of malaria in the Republic of Cabo Verde. Parasitology 118:347-355. http://dx.doi.org/10.1017/S0031182099003972.
33. Snow RW, Gilles HM. 2002. The epidemiology of malaria, p 85-106. In Warrell DA, Gilles HM (ed), Essential malariology, 4th ed. Edward Arnold, London, United Kingdom.
34. Luby JP, Collins WE, Kaiser RL. 1967. Persistence of malarial antibody. Findings in patients infected during the outbreak of malaria in Lake Vera, California, 1952-1953. Am. J. Trop. Med. Hyg. 16:255-257.
35. Druilhe P, Pradier O, Marc JP, Miltgen F, Mazier D, Parent G. 1986. Levels of antibodies to Plasmodium falciparum sporozoite surfaceantigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect. Immun. 53:393-397.
36. Braga EM, Fontes CJ, Krettli AU. 1998. Persistence of humoral response against sporozoite and blood-stage malaria antigens 7 years after a brief exposure to Plasmodium vivax. J. Infect. Dis. 177:1132-1135. http://dx.doi.org/10.1086/517412.
37. Lim KJ, Park JW, Yeom JS, Lee YH, Yoo SB, Oh JH, Sohn MJ, Bahk YY, Kim YS. 2004. Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax. Parasitol. Res. 92:384-389. http://dx.doi.org/10.1007/s00436-003-1009-0.
38. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM. 2005. Estimating medium-and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc. Natl. Acad. Sci. U.S.A. 102:5108-5113. http://dx.doi.org/10.1073/pnas.0408725102.
39. Slifka MK, Ahmed R. 1998. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 10:252-258. http://dx.doi.org/10.1016/S0952-7915(98)80162-3.
40. Wipasa J, Suphavilai C, Okell LC, Cook J, Corran PH, Thaikla K, Liewsaree W, Riley EM, Hafalla JC. 2010. Long-lived antibody and B cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog. 6:e1000770. http://dx.doi.org/10.1371/journal.ppat.1000770.
41. Bilsborough J, Carlisle M, Good MF. 1993. Identification of Caucasian CD4 T cell epitopes on the circumsporozoite protein of Plasmodium vivax. T cell memory. J. Immunol. 151:890-899.
42. Sakihama N, Kaneko A, Hattori T, Tanabe K. 2001. Limited recombination events in merozoite surface protein-1 alleles of Plasmodium falciparum on islands. Gene 279:41-48. http://dx.doi.org/10.1016/S0378-1119(01)00748-X.
43. Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneko A, Kanbara H, Hattori T, Tanabe K. 2002. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc. Natl. Acad. Sci. U.S.A. 99:16348-16353. http://dx.doi.org/10.1073/pnas.252348999.
44. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NP, Anderson TJ, White NJ. 2007. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195:927-933. http://dx.doi.org/10.1086/512241.
45. Laserson KF, Petralanda I, Almera R, Barker RH, Jr, Spielman A, Maguire JH, Wirth DF. 1999. Genetic characterization of an epidemic of Plasmodium falciparum malaria among Yanomami Amerindians. J. Infect. Dis. 180:2081-2085. http://dx.doi.org/10.1086/315144.
46. Mueller I, Kaiok J, Reeder JC, Cortes A. 2002. The population structure of Plasmodium falciparum and Plasmodium vivax during an epidemic of malaria in the Eastern Highlands of Papua New Guinea. Am. J. Trop. Med. Hyg. 67:459-464. http://www.ajtmh.org/content/67/5/459.long.
47. Tanabe K, Sakihama N, Kaneko A. 2004. Stable SNPs in malaria antigen genes in isolated populations. Science 303:493. http://dx.doi.org/10.1126/science.1092077.
48. Farnert A, Snounou G, Rooth I, Bjorkman A. 1997. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am. J. Trop. Med. Hyg. 56:538-547.
49. Jeffery GM. 1966. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull. World Health Organ. 35:873-882.
50. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, Sauerwein RW. 2007. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am. J. Trop. Med. Hyg. 76:470-474. http://www.ajtmh.org/content/76/3/470.long.
51. Alves FP, Gil LH, Marrelli MT, Ribolla PE, Camargo EP, Da Silva LH. 2005. Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. J. Med. Entomol. 42:777-779. http://dx.doi.org/10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2.